Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angel Healthcare Investors was a Boston-area angel investment group focused on funding early-stage healthcare and life sciences companies. The organization invested across medical devices, biotechnology, healthcare services, diagnostics, and healthcare information technology rather than developing therapeutics itself. It appears to have operated as a private investor network led by experienced healthcare executives and entrepreneurs, with managing directors including Mary McNamara and Robyn C. Davis. Public business databases now describe the firm as closed or permanently closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Angel Healthcare Investors.